Jeffrey Kraws

Chief Executive Officer and Co-Founder, Crystal Research Associates LLC Mr. Kraws ranks in the top ten analysts for pharmaceutical stock performance in the world, and Starmine and Zacks have both ranked him as number one stock picker for pharmaceuticals. His experience includes Senior Pharmeceutical Analyst at Evern Securities, Asea Brown Boveri, Nationsbanc Montgomery Securities, BT …Read More

Aubrey Dan

Aubrey Dan

Mr. Aubrey Dan is a Canadian businessman, philanthropist and Tony-Award® winning producer (MEMPHIS) as well as the Principal of the Dancap Family Investment Office (dancap.ca). Mr. Dan joined Novopharm Ltd. following his graduation from Western University in the role of Sales Representative, progressing to the position of Director of Sales. He later served as President …Read More

Paul Mesburis

Paul Mesburis

Mr. Paul Mesburis is the Managing Principal of Empyrean Capital, and has more than twenty years of international experience in financial and capital markets. On the buy-side, he has managed portfolios for global investment strategies in both debt and equities. On the sell-side, his experience includes senior roles in mergers and acquisitions, investment banking, and …Read More

David Hankinson

Former President and CEO of Solvay Pharma Inc. Co-founded a pharmaceutical distribution operation as VP of Kingswood Canada Inc. Prior work experience includes 15 years in various positions at Eli Lilly

Graham Burton PhD

Co-founded Avivagen after 19 years of work in the biomedical field at the National Research Council of Canada (NRC). At NRC developed the foundation for Avivagen’s oxidized β-carotene technology. Internationally known as a leading scientist in vitamin E research.

Kym Anthony

Mr. Anthony has extensive experience in capital markets, agriculture and life sciences and invested in the Company concurrent with his appointment. He is currently Chair of the Audit Committee and Vice Chair of the Board of ComDev International. 2011 to May 2014 Chair of Prometic Life Sciences Inc 2007 to Present Chair, Hybrid Partners and …Read More